Serum  	Serum  	 JJ	B-NP
anti-endometrial  	anti-endometrial  	 JJ	I-NP
antibodies  	antibodies  	 NNS	I-NP
and  	and  	 CC	O
first  	first  	 JJ	O
trimester  	trimester  	 JJ	B-NP
pregnancy  	pregnancy  	 NN	I-NP
loss  	loss  	 NN	I-NP
Serum  	Serum  	 NNP	I-NP
anti-endometrial  	anti-endometrial  	 JJ	I-NP
antibodies  	antibodies  	 NNS	I-NP
( 	( 	 -LRB-	O
AEA 	AEA 	 NNP	B-NP
)  	)  	 -RRB-	O
have  	have  	 VBP	O
been  	been  	 VBN	O
studied  	studied  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
marker  	marker  	 NN	O
for  	for  	 IN	O
endometriosis  	endometriosis  	 NN	B-NP
and  	and  	 CC	O
implantation  	implantation  	 JJ	B-NP
failure 	failure 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
sought  	sought  	 VBD	O
to  	to  	 TO	O
determine  	determine  	 VB	O
if  	if  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
AEA  	AEA  	 NNP	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
serum  	serum  	 NN	B-NP
of  	of  	 IN	O
pregnant  	pregnant  	 JJ	O
patients  	patients  	 NNS	O
is  	is  	 VBZ	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
first  	first  	 JJ	O
trimester  	trimester  	 JJ	B-NP
pregnancy  	pregnancy  	 NN	I-NP
loss  	loss  	 NN	I-NP
including  	including  	 VBG	O
complete  	complete  	 JJ	O
abortion 	abortion 	 NN	B-NP
.  	.  	 .	O
This  	This  	 DT	O
is  	is  	 VBZ	O
a  	a  	 DT	O
prospective  	prospective  	 JJ	B-NP
pilot  	pilot  	 NN	I-NP
case  	case  	 NN	I-NP
control  	control  	 NN	I-NP
study  	study  	 NN	I-NP
of  	of  	 IN	O
30  	30  	 CD	O
patients  	patients  	 NNS	O
presenting  	presenting  	 VBG	O
with  	with  	 IN	O
first  	first  	 JJ	O
trimester  	trimester  	 JJ	B-NP
pregnancy  	pregnancy  	 NN	I-NP
loss  	loss  	 NN	I-NP
compared  	compared  	 VBN	O
to  	to  	 TO	O
a  	a  	 DT	O
control  	control  	 NN	B-NP
group  	group  	 NN	I-NP
of  	of  	 IN	O
30  	30  	 CD	O
first  	first  	 JJ	O
trimester  	trimester  	 JJ	B-NP
pregnant  	pregnant  	 JJ	I-NP
patients  	patients  	 NNS	I-NP
with  	with  	 IN	O
a  	a  	 DT	O
normal  	normal  	 JJ	B-NP
course  	course  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
serum  	serum  	 JJ	B-NP
AEA 	AEA 	 NNP	I-NP
.  	.  	 .	O
The  	The  	 DT	O
control  	control  	 NN	B-NP
group  	group  	 NN	I-NP
was  	was  	 VBD	O
selected  	selected  	 VBN	O
using  	using  	 VBG	O
propensity  	propensity  	 JJ	O
matching  	matching  	 NN	O
of  	of  	 IN	O
patient  	patient  	 JJ	O
characteristics 	characteristics 	 NNS	O
.  	.  	 .	O
AEA  	AEA  	 NNP	B-NP
assays  	assays  	 NN	I-NP
were  	were  	 VBD	O
performed  	performed  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
operator  	operator  	 NN	B-NP
blinded  	blinded  	 NN	I-NP
to  	to  	 TO	O
clinical  	clinical  	 JJ	B-NP
status  	status  	 NN	I-NP
of  	of  	 IN	O
patients 	patients 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
mean  	mean  	 JJ	O
maternal  	maternal  	 JJ	B-NP
age  	age  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
study  	study  	 NN	O
and  	and  	 CC	O
control  	control  	 NN	B-NP
groups  	groups  	 NNS	I-NP
was  	was  	 VBD	O
not  	not  	 RB	O
statistically  	statistically  	 RB	O
significant  	significant  	 JJ	O
( 	( 	 -LRB-	O
26.1  	26.1  	 CD	O
+ 	+ 	 CD	O
/ 	/ 	 CD	O
-  	-  	 :	O
5.7  	5.7  	 CD	O
vs.  	vs.  	 IN	O
24.2  	24.2  	 CD	O
+ 	+ 	 CD	O
/ 	/ 	 CD	O
-  	-  	 :	O
4.5  	4.5  	 CD	O
years 	years 	 NNS	O
,  	,  	 ,	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.155 	0.155 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
A  	A  	 DT	O
history  	history  	 NN	O
of  	of  	 IN	O
pregnancy  	pregnancy  	 NN	B-NP
loss  	loss  	 NN	I-NP
was  	was  	 VBD	O
not  	not  	 RB	O
significantly  	significantly  	 RB	O
greater  	greater  	 JJR	O
in  	in  	 IN	O
the  	the  	 DT	O
study  	study  	 NN	B-NP
group  	group  	 NN	I-NP
( 	( 	 -LRB-	O
12 	12 	 CD	O
/ 	/ 	 CD	O
30  	30  	 CD	O
=  	=  	 SYM	O
40.0 	40.0 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
as  	as  	 RB	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
control  	control  	 NN	B-NP
group  	group  	 NN	I-NP
( 	( 	 -LRB-	O
8 	8 	 CD	O
/ 	/ 	 CD	O
30  	30  	 CD	O
=  	=  	 SYM	O
26.7 	26.7 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.412 	0.412 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
both  	both  	 DT	O
study  	study  	 NN	O
and  	and  	 CC	O
control  	control  	 NN	B-NP
groups 	groups 	 NNS	I-NP
,  	,  	 ,	O
40 	40 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
samples  	samples  	 NNS	O
tested  	tested  	 VBD	O
positive  	positive  	 JJ	O
for  	for  	 IN	O
AEA 	AEA 	 NNP	B-NP
;  	;  	 :	O
therefore 	therefore 	 RB	O
,  	,  	 ,	O
we  	we  	 PRP	O
found  	found  	 VBD	O
no  	no  	 DT	O
evidence  	evidence  	 NN	O
of  	of  	 IN	O
an  	an  	 DT	O
association  	association  	 NN	O
between  	between  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
AEA  	AEA  	 NNP	B-NP
and  	and  	 CC	O
pregnancy  	pregnancy  	 NN	B-NP
loss 	loss 	 NN	I-NP
.  	.  	 .	O
These  	These  	 DT	O
findings  	findings  	 NNS	O
in  	in  	 IN	O
our  	our  	 PRP$	O
pilot  	pilot  	 NN	O
study  	study  	 NN	O
suggest  	suggest  	 VBP	O
that  	that  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
serum  	serum  	 JJ	B-NP
AEA  	AEA  	 NNP	I-NP
does  	does  	 VBZ	O
not  	not  	 RB	O
appear  	appear  	 VB	O
to  	to  	 TO	O
be  	be  	 VB	O
a  	a  	 DT	O
marker  	marker  	 NN	O
for  	for  	 IN	O
early  	early  	 JJ	O
pregnancy  	pregnancy  	 NN	B-NP
loss 	loss 	 NN	I-NP
.  	.  	 .	O
